Feeney GF - Search Results

1

Wernicke-Korsakoff syndrome (WKS) in Australia: no room for complacency.

Feeney GF, Connor JP. Feeney GF, et al. Drug Alcohol Rev. 2008 Jul;27(4):388-92. doi: 10.1080/09595230802090048. Drug Alcohol Rev. 2008. PMID: 18584388

2

Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?

Feeney GF, Young RM, Connor JP, Tucker J, McPherson A. Feeney GF, et al. Aust N Z J Psychiatry. 2002 Oct;36(5):622-8. doi: 10.1046/j.1440-1614.2002.01019.x. Aust N Z J Psychiatry. 2002. PMID: 12225445

3

Alcohol dependence: the impact of cognitive behaviour therapy with or without naltrexone on subjective health status.

Feeney GF, Connor JP, Young RM, Tucker J, McPherson A. Feeney GF, et al. Aust N Z J Psychiatry. 2004 Oct;38(10):842-8. doi: 10.1080/j.1440-1614.2004.01469.x. Aust N Z J Psychiatry. 2004. PMID: 15369544 Clinical Trial.

4

Review: acamprosate and naltrexone are safe and effective but have low compliance rates for people with alcohol dependence.

Feeney GF, Connor JP. Feeney GF, et al. Evid Based Ment Health. 2005 Feb;8(1):14. doi: 10.1136/ebmh.8.1.14. Evid Based Ment Health. 2005. PMID: 15671505 Free article. No abstract available.

5

Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.

Feeney GF, Connor JP, Young RM, Tucker J, McPherson A. Feeney GF, et al. Alcohol Alcohol. 2006 May-Jun;41(3):321-7. doi: 10.1093/alcalc/agl007. Epub 2006 Feb 8. Alcohol Alcohol. 2006. PMID: 16467406 Clinical Trial.

6

Is acamprosate use in alcohol dependence treatment reflected in improved subjective health status outcomes beyond cognitive behavioural therapy alone?

Feeney GF, Connor JP, McD Young R, Tucker J, McPherson A. Feeney GF, et al. J Addict Dis. 2006;25(4):49-58. doi: 10.1300/J069v25n04_05. J Addict Dis. 2006. PMID: 17088225

7

The validity of the Brief Michigan Alcohol Screening Test (bMAST) as a problem drinking severity measure.

Connor JP, Grier M, Feeney GF, Young RM. Connor JP, et al. Among authors: feeney gf. J Stud Alcohol Drugs. 2007 Sep;68(5):771-79. doi: 10.15288/jsad.2007.68.771. J Stud Alcohol Drugs. 2007. PMID: 17690811

8

Validity of the obsessive compulsive drinking scale in a heavy drinking population.

Connor JP, Jack A, Feeney GF, Young RM. Connor JP, et al. Among authors: feeney gf. Alcohol Clin Exp Res. 2008 Jun;32(6):1067-73. doi: 10.1111/j.1530-0277.2008.00668.x. Epub 2008 Apr 26. Alcohol Clin Exp Res. 2008. PMID: 18445115

9

The cost effectiveness of naltrexone added to cognitive-behavioral therapy in the treatment of alcohol dependence.

Walters D, Connor JP, Feeney GF, Young RM. Walters D, et al. Among authors: feeney gf. J Addict Dis. 2009;28(2):137-44. doi: 10.1080/10550880902772456. J Addict Dis. 2009. PMID: 19340676

10

The obsessive compulsive drinking scale is a valid measure of alcohol craving in young adults.

Connor JP, Feeney GF, Jack A, Young RM. Connor JP, et al. Among authors: feeney gf. Alcohol Clin Exp Res. 2010 Dec;34(12):2155-61. doi: 10.1111/j.1530-0277.2010.01312.x. Epub 2010 Sep 22. Alcohol Clin Exp Res. 2010. PMID: 20860612

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters